Related Experiment Video
Updated: Jan 14, 2026

Noninvasive and Invasive Renal Hypoxia Monitoring in a Porcine Model of Hemorrhagic Shock
Published on: October 28, 2022
Bleeding in Patients with Renal Impairment: A Current Perspective
Robyn Yun-Ching Haysom1,2, Nadir Aziz2,3, Dawn Swan4
1Department of Geriatric Medicine, University Hospitals of North Midlands, Stoke-on-Trent, United Kingdom.
Insights
Patients with chronic kidney disease (CKD) face frequent bleeding complications due to multiple factors. Albuminuria may offer a better way to assess bleeding risk in these patients.
Area of Science:
- Nephrology
- Hematology
- Internal Medicine
Background:
- Bleeding complications are common and significant in chronic kidney disease (CKD), worsening with declining kidney function and dialysis.
- The tendency for bleeding in CKD is multifactorial, involving platelet dysfunction, uremic/inflammatory states, renal anemia, and anticoagulant use.
Purpose of the Study:
- To review the mechanisms of bleeding in CKD.
- To highlight the limitations of current bleeding risk assessment tools in CKD patients.
- To explore the potential of albuminuria as a marker for improved bleeding risk stratification.
Main Methods:
- Literature review summarizing pathophysiological mechanisms of bleeding in CKD.
- Analysis of the impact of dialysis and declining renal function on hemostasis.
- Evaluation of emerging evidence on albuminuria as a bleeding risk marker.
Main Results:
- Bleeding in CKD results from impaired hemostasis due to platelet dysfunction, uremia, anemia, and anticoagulation.
- Existing bleeding risk tools are inadequate for the CKD population.
- Albuminuria shows promise as an independent marker for renal dysfunction and hemorrhage risk.
Conclusions:
- There is a significant unmet need for CKD-specific bleeding risk assessment tools.
- Albuminuria may improve the stratification of bleeding risk in patients with chronic kidney disease.
- Understanding multifactorial bleeding mechanisms is crucial for clinical management.
Abstract:
Bleeding complications are a frequent and clinically significant problem in patients with chronic kidney disease (CKD), with prevalence increasing as kidney function declines, and in those receiving dialysis. The bleeding tendency in CKD is multifactorial: arising from platelet dysfunction, uremic/inflammatory states, renal anemia, and the common concurrent use of anticoagulants in this population. Together, these mechanisms all contribute to impairment in hemostasis and increased risk of both spontaneous and procedural-hemorrhages. Current bleeding risk assessment tools perform poorly in the CKD population, limiting their utility for guiding clinical decision-making. Emerging evidence suggests that albuminuria, as an independent marker for both renal dysfunction and hemorrhage risk, may improve bleeding risk stratification in this cohort. This review summarizes the pathophysiological mechanisms underlying bleeding in CKD and the impact of dialysis and declining renal function. It also highlights the unmet need for more accurate, CKD-specific bleeding risk assessment tools.
More Related Videos
08:505/6th Nephrectomy in Combination with High Salt Diet and Nitric Oxide Synthase Inhibition to Induce Chronic Kidney Disease in the Lewis Rat
Published on: July 3, 2013
07:11Surgical Techniques for Catheter Placement and 5/6 Nephrectomy in Murine Models of Peritoneal Dialysis
Published on: July 19, 2018
Related Concept Videos
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Acute Kidney Injury V: Interprofessional Care
Drug Dosing in Renal Diseases: Dose Adjustments Based on Drug Clearance and Elimination Rate Constant
Renal Failure: Dose Adjustments
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
Acute Kidney Injury II: Pathophysiology
Acute Kidney Injury I: Introduction